Preparation of a novel monoclonal antibody against the antimalarial drugs, artemisinin and artesunate

Planta Med. 2007 Aug;73(10):1127-32. doi: 10.1055/s-2007-981560. Epub 2007 Jul 5.

Abstract

A monoclonal antibody (MAb) 1C1 against artemisinin was prepared by a cell fusion with splenocytes and aminopterin-sensitive myeloma cells, SP2/0. An artesunate-BSA conjugate was used as immunogen to raise antibodies specific to artemisinin. The prepared anti-artemisinin MAb-1C1 have a novel characteristic which shows a specificity to compounds that are structurally related to artemisinin such as artesunate (630%) and dihydroartemisinin (29.9%). By using MAb-1C1, a specific and reliable ELISA was developed for the detection of compounds structurally related to artemisinin. The system shows a full measuring range from 2 to 20 microg/mL in the case of artemisinin and from 4 to 125 ng/mL in the case of artesunate in the competitive ELISA, and was validated to be of use for surveying and breeding of Artemisia annua containing a high amount of artemisinin as well as for the characterization of the pharmacokinetics of artemisinin and its derivatives.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis*
  • Antibodies, Monoclonal / chemistry
  • Antimalarials / analysis*
  • Artemisia annua*
  • Artemisinins / analysis*
  • Artesunate
  • Enzyme-Linked Immunosorbent Assay / methods
  • Malaria, Falciparum / drug therapy
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Phytotherapy*
  • Plasmodium falciparum
  • Sesquiterpenes / analysis*

Substances

  • Antibodies, Monoclonal
  • Antimalarials
  • Artemisinins
  • Sesquiterpenes
  • Artesunate
  • artemisinin